NO20045029L - Polypeptider og biosyntetiske ruter - Google Patents

Polypeptider og biosyntetiske ruter

Info

Publication number
NO20045029L
NO20045029L NO20045029A NO20045029A NO20045029L NO 20045029 L NO20045029 L NO 20045029L NO 20045029 A NO20045029 A NO 20045029A NO 20045029 A NO20045029 A NO 20045029A NO 20045029 L NO20045029 L NO 20045029L
Authority
NO
Norway
Prior art keywords
indole
polypeptides
methods
pyruvate
hydroxy
Prior art date
Application number
NO20045029A
Other languages
English (en)
Inventor
Timothy W Abraham
Douglas C Cameron
Joseph Dalluge
Paula M Hicks
Russell J Hobson
Sara C Mcfarlan
Jim Millis
John Rosazza
Lishan Zhao
David P Weiner
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29270554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20045029(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of NO20045029L publication Critical patent/NO20045029L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0014—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4)
    • C12N9/0016—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on the CH-NH2 group of donors (1.4) with NAD or NADP as acceptor (1.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

2005 -01- 0 4 Det er tilveiebragt fremgangsmåter og sammensetninger som kan brukes for å fremstille monatin fra glukose, tryptofan, indol-3-melkesyre, indol-3-pyruvat og 2-hydroksy-2(indol-3-ylmetyl)-4-ketoglutarsyre. Det er også beskrevet fremgangsmåter for å fremstille indol3-pyruvatet og 2-hydroksy-2--(indol-3-ylmetyl)4-ketoglutarsyremellomprodukter. Det er tilveiebragt sammensetninger som inkluderer nukleinsyremolekyler, polypeptider, kjemiske strukturer og celler. Fremgangsmåtene innbefatter in vitro og in vivo prosesser, og in vitro metodene innbefatter kjemiske reaksjoner.
NO20045029A 2002-04-23 2004-11-19 Polypeptider og biosyntetiske ruter NO20045029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37483102P 2002-04-23 2002-04-23
PCT/US2003/012588 WO2003091396A2 (en) 2002-04-23 2003-04-23 Polypeptides and biosynthetic pathways

Publications (1)

Publication Number Publication Date
NO20045029L true NO20045029L (no) 2005-01-04

Family

ID=29270554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045029A NO20045029L (no) 2002-04-23 2004-11-19 Polypeptider og biosyntetiske ruter

Country Status (24)

Country Link
US (1) US20040063175A1 (no)
EP (2) EP1503985B1 (no)
JP (3) JP2005523696A (no)
KR (1) KR100902813B1 (no)
CN (1) CN100516043C (no)
AT (1) ATE491803T1 (no)
AU (2) AU2003263097A1 (no)
BR (1) BRPI0309527B1 (no)
CA (1) CA2483126C (no)
CO (1) CO5631430A2 (no)
DE (1) DE60335361D1 (no)
EA (1) EA009284B1 (no)
EC (1) ECSP045381A (no)
ES (1) ES2356132T3 (no)
GE (1) GEP20084387B (no)
IL (1) IL164548A0 (no)
MX (1) MXPA04010522A (no)
NO (1) NO20045029L (no)
NZ (2) NZ535297A (no)
PL (2) PL208481B1 (no)
RS (1) RS92604A (no)
SG (1) SG146453A1 (no)
WO (1) WO2003091396A2 (no)
ZA (1) ZA200408379B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1466890B1 (en) 2001-12-27 2012-04-04 Ajinomoto Co., Inc. Processes for the preparation of glutamic acid compounds and intermediates thereof and novel intermediates used in the processes
US7297800B2 (en) 2001-12-27 2007-11-20 Ajinomoto Co., Inc. Process of producing glutamate derivatives
EP2460884A3 (en) * 2001-12-27 2013-03-27 Ajinomoto Co., Inc. Process for preparing monatin
US8372989B2 (en) * 2002-04-23 2013-02-12 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of monatin and its precursors
US7572607B2 (en) 2002-04-23 2009-08-11 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of monatin and its precursors
ATE463568T1 (de) 2002-08-26 2010-04-15 Ajinomoto Kk Neue aldolasen und verfahren zur herstellung von substituierter alpha-ketosäure
US7414119B2 (en) * 2002-09-20 2008-08-19 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them
KR100723826B1 (ko) 2002-12-09 2007-06-04 아지노모토 가부시키가이샤 변이형 ｄ－아미노트랜스퍼라제 및 이를 사용하는 광학활성글루탐산 유도체의 제조방법
JP4760375B2 (ja) * 2003-06-26 2011-08-31 味の素株式会社 Ｉｈｏｇの回収方法およびモナティンの製造方法
KR20060061811A (ko) * 2003-08-01 2006-06-08 카아길, 인코포레이팃드 모나틴 식탁용 감미제 조성물 및 이의 제조 방법
MXPA06001663A (es) * 2003-08-14 2006-07-03 Cargill Inc Composiciones de goma de mascar que comprenden monatina y metodos para hacer las mismas.
AU2004268594A1 (en) * 2003-08-25 2005-03-10 Cargill, Incorporated Beverage compositions comprising monatin and methods of making same
DE602004031444D1 (de) * 2003-10-21 2011-03-31 Cargill Inc Herstellung von monatin und monatinvorstufen
JP4797452B2 (ja) * 2004-06-07 2011-10-19 味の素株式会社 新規アルドラーゼ並びに光学活性ｉｈｏｇ及びモナティンの製造方法
CA2506247C (en) 2004-06-07 2012-02-21 Ajinomoto Co., Inc. Novel aldolase, and method for producing optically active ihog and monatin
US7180370B2 (en) * 2004-09-01 2007-02-20 Micron Technology, Inc. CMOS amplifiers with frequency compensating capacitors
US8158389B2 (en) * 2005-04-20 2012-04-17 Cargill, Incorporated Products and methods for in vivo secretion of monatin
US8153405B2 (en) 2005-04-20 2012-04-10 Cargill, Incorporated Products and methods for in vivo secretion of monatin
US7582455B2 (en) 2005-04-26 2009-09-01 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
WO2007133184A2 (en) 2005-04-26 2007-11-22 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
US8076108B2 (en) 2005-04-26 2011-12-13 Cargill, Incorporated Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
BRPI0708673A2 (pt) 2006-03-07 2011-06-07 Cargill Inc método para fabricação de polipeptìdeos com atividade de aldolase e polinucleotìdeos que codificam estes polipeptìdeos
EA029538B1 (ru) 2006-03-07 2018-04-30 Басф Энзаймс Ллк Полипептид, обладающий активностью альдолазы, полинуклеотид, кодирующий этот полипептид, и способы получения и применения полинуклеотида и полипептида
US20090198072A1 (en) * 2006-05-24 2009-08-06 Cargill, Incorporated Methods and systems for increasing production of equilibrium reactions
CA2653054A1 (en) 2006-05-24 2007-12-06 Cargill, Incorporated Methods and systems for increasing production of equilibrium reactions
CN101239941B (zh) * 2007-02-08 2012-02-29 味之素株式会社 光学活性化合物的制造方法
WO2009028338A1 (ja) 2007-08-24 2009-03-05 Ajinomoto Co., Inc. 新規オキシダーゼ遺伝子、および該遺伝子を利用する３－インドールピルビン酸の製造方法
US8003361B2 (en) * 2007-10-01 2011-08-23 Cargill Incorporated Production of monatin enantiomers
US8367847B2 (en) * 2007-10-01 2013-02-05 Cargill, Incorporated Production of monatin enantiomers
US8076107B2 (en) 2007-10-01 2011-12-13 Cargill, Incorporated Production of monatin stereoisomers
BRPI0822219A2 (pt) * 2008-01-03 2014-11-04 Cargill Inc Ácidos nucléicos de aminotransferase e oxidoreductase e polipeptídeos e métodos de uso.
PL2238242T3 (pl) 2008-01-03 2015-06-30 Basf Enzymes Llc Transferazy i oksydoreduktazy, kwasy nukleinowe kodujące je oraz sposoby ich wytwarzania i zastosowania
JP2012527897A (ja) 2009-05-28 2012-11-12 カーギル・インコーポレイテッド 常温長期保存可能モナチン甘味付け飲料
CN102686391A (zh) 2009-12-30 2012-09-19 嘉吉公司 聚合物及制备和使用聚合物的方法
US8445226B2 (en) * 2010-02-01 2013-05-21 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
US9023627B2 (en) 2010-09-15 2015-05-05 University Of Washington Through Its Center For Commercialization Systems and methods for biotransformation of carbon dioxide into higher carbon compounds
CN102741406A (zh) 2010-10-14 2012-10-17 味之素株式会社 用于产生莽那亭的方法
WO2012135389A2 (en) * 2011-03-28 2012-10-04 The Regents Of The University Of California Host cells and methods for oxidizing aromatic amino acids
WO2012147674A1 (ja) * 2011-04-25 2012-11-01 味の素株式会社 モナティンの製造方法
GB201412545D0 (en) * 2014-07-15 2014-08-27 Univ Manchester The And Manchester Metropolitan University Enzymatic processes and uses
CN112931181A (zh) * 2021-01-28 2021-06-11 西北农林科技大学 一种抗根肿病橙色大白菜新种质的选育方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002889A (en) * 1960-06-20 1961-10-03 Kyowa Hakko Kogyo Kk Method of producing l-glutamic acid
US3128237A (en) * 1961-02-24 1964-04-07 Ajinomoto Kk Process for producing l-glutamic acid by bacterial fermentation
US4371614A (en) * 1980-08-22 1983-02-01 Ajinomoto Co., Inc. E.Coli bacteria carrying recombinant plasmids and their use in the fermentative production of L-tryptophan
JPH0691827B2 (ja) * 1981-12-17 1994-11-16 協和醗酵工業株式会社 新規ベクタ−プラスミド
JPS60176593A (ja) * 1984-02-22 1985-09-10 Kyowa Hakko Kogyo Co Ltd Ｌ−トリプトフアンの製造法
US5264550A (en) 1985-04-15 1993-11-23 Scios Nova Inc. Human anti-inflammatory phospholipase inhibitor protein
EP0232262A4 (en) 1985-08-15 1989-09-19 Stauffer Chemical Co MICROORGANISM PRODUCING TRYPTOPHANE.
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
GB2205834B (en) 1987-06-15 1990-10-31 South African Inventions 3-(1-amino-1,3-dicarboxy-3-hydroxy-but-4-yl)-indole compounds
US5300437A (en) * 1989-06-22 1994-04-05 Celgene Corporation Enantiomeric enrichment and stereoselective synthesis of chiral amines
GB2240105B (en) 1990-01-19 1993-06-09 Technology Finance Corp Process for the production of 3-(1-amino-1,3-dicarboxy-3-hydroxy-but-4-yl) indole
US5173497A (en) * 1990-05-17 1992-12-22 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
EP0861893A3 (en) 1991-09-19 1999-11-10 Genentech, Inc. High level expression of immunoglobulin polypeptides
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5360724A (en) * 1992-12-18 1994-11-01 Celgene Corporation Process for the preparation of chiral 1-aryl-2-aminopropanes
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
JP3698742B2 (ja) 1994-03-01 2005-09-21 協和醗酵工業株式会社 光学活性４−ヒドロキシ−２−ケトグルタル酸の製造法
US5888783A (en) * 1994-08-30 1999-03-30 Ajinomoto Co., Inc. Methods for producing L-valine and L-leucine
WO1996008567A1 (en) * 1994-09-16 1996-03-21 Texas A & M University System Microorganisms and methods for overproduction of dahp by cloned pps gene
US5985617A (en) * 1997-02-18 1999-11-16 Liao; James C. Microorganisms and methods for overproduction of DAHP by cloned PPS gene
US5843782A (en) * 1995-02-09 1998-12-01 Novaflora, Inc. Micropropagation of rose plants
GB2304718B (en) * 1995-09-05 2000-01-19 Degussa The production of tryptophan by the bacterium escherichia coli
CA2234412C (en) * 1997-06-09 2008-09-02 Kyowa Hakko Kogyo Co., Ltd. Method for producing optically active compound
US5994559A (en) 1998-08-06 1999-11-30 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Synthesis of monatin-A high intensity natural sweetener
EP1637160A3 (en) 1999-05-07 2006-05-03 Genentech, Inc. Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
US6428504B1 (en) * 2000-04-06 2002-08-06 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
JP2002060382A (ja) * 2000-08-22 2002-02-26 Ajinomoto Co Inc モナティンの立体異性体及びその使用、並びにモナティン類の製造方法及びそのための中間体
JP3713224B2 (ja) * 2001-08-10 2005-11-09 株式会社三栄水栓製作所 水栓取替方法
EP2460884A3 (en) * 2001-12-27 2013-03-27 Ajinomoto Co., Inc. Process for preparing monatin

Also Published As

Publication number Publication date
AU2010201699A1 (en) 2010-05-20
JP2005523696A (ja) 2005-08-11
PL208481B1 (pl) 2011-05-31
PL373423A1 (en) 2005-08-22
CA2483126A1 (en) 2003-11-06
ZA200408379B (en) 2006-05-31
JP4988803B2 (ja) 2012-08-01
DE60335361D1 (de) 2011-01-27
CA2483126C (en) 2014-05-20
EP1503985A2 (en) 2005-02-09
ATE491803T1 (de) 2011-01-15
AU2003263097A1 (en) 2003-11-10
EP1503985B1 (en) 2010-12-15
ECSP045381A (es) 2005-01-03
EP2354240A1 (en) 2011-08-10
EP1503985A4 (en) 2006-11-02
KR20080056274A (ko) 2008-06-20
CN1656068A (zh) 2005-08-17
EA200401228A1 (ru) 2006-04-28
IL164548A0 (en) 2005-12-18
BRPI0309527B1 (pt) 2015-08-18
WO2003091396A2 (en) 2003-11-06
NZ535297A (en) 2008-05-30
EA009284B1 (ru) 2007-12-28
JP2011250806A (ja) 2011-12-15
KR100902813B1 (ko) 2009-06-12
US20040063175A1 (en) 2004-04-01
PL208998B1 (pl) 2011-07-29
NZ555884A (en) 2008-10-31
AU2010201699B2 (en) 2013-02-07
GEP20084387B (en) 2008-06-10
SG146453A1 (en) 2008-10-30
RS92604A (en) 2007-09-21
BR0309527A (pt) 2005-06-28
ES2356132T3 (es) 2011-04-05
MXPA04010522A (es) 2004-12-13
WO2003091396A3 (en) 2004-03-11
JP2010004896A (ja) 2010-01-14
CO5631430A2 (es) 2006-04-28
EP2354240B1 (en) 2016-07-06
JP5351230B2 (ja) 2013-11-27
CN100516043C (zh) 2009-07-22

Similar Documents

Publication Publication Date Title
NO20045029L (no) Polypeptider og biosyntetiske ruter
BRPI0415763A (pt) produção de monatina e precursores de monatina
DK1224170T3 (da) I 6-position substitueret indolin, fremstilling og anvendelse deraf som lægemiddel
HK1162587A1 (en) Non-tumorigenic mdck cell line for propagating viruses mdck
DE602006020482D1 (de) 1,5-substituierte indol-2-yl amidderivative
DE112005001826T5 (de) Randgeschützte katalysatorbeschichtete Membranelektrodenanordnungen
DK1248867T3 (da) Selektiv elektrokemisk reduktion af halogenerede 4-aminopicolinsyrer
IL188998A0 (en) Supported gold catalyst and methods for the production thereof
DE602006009901D1 (de) Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin
IS2889B (is) Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun
DE60031709D1 (de) Zusammensetzungen für die elektroporation
WO2006081463A3 (en) Thermococcus zilligii dna polymerases and variants thereof
NO20043400L (no) Fremgangsmater for nukleinsyreamplifisering
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
DK1354876T3 (da) Fremgangsmåde til syntese af (2S,3aS,7aS)-perhydroindol-2-carboxylsyre og dennes estere og anvendelse heraf i syntesen af perindopril
CU20040242A7 (es) Polipéptidos y pasos biosintéticos
DE602004009583D1 (de) Piperidin- oder 8-azabicycloä3.2.1üoct-3-ylderivate, die sich als modulatoren der chemokinrezeptoraktivität eignen
DK1748043T3 (da) Polysubstituerede 1,1-pyridinyloxycyclopropanaminderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK1319668T3 (da) Fremgangsmåde til syntese af (2S, 3aS, 7aS)-1-((S)-alanyl)-octahydro-1H-indol-2-carboxylsyrederivater og anvendelse heraf ved syntese af perindopril
DK1338591T3 (da) Fremgangsmåde til syntese af (2S,3aS,7aS)-perhydroindol-2-carboxylsyre og estere heraf samt anvendelse heraf ved syntese af perindopril
DE60030428D1 (de) 4-cyano-3-hydroxy-butanoyl hydrazine, derivate und verfahren zu ihrer herstellung
NO20043613L (no) Genetisk polymorfi i preprotachykiningenet
DE60232258D1 (de) Lipid-aminoglykosid konjugate zur transfektion
DE602004008002D1 (de) Herstellungsverfahren für hochreines tricyclo-(5.2.1.0 2,6)dekan-2-Carboxylsäureester

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application